Cargando…
Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI)
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652556/ http://dx.doi.org/10.1186/2051-1426-3-S2-P384 |
_version_ | 1782401779739131904 |
---|---|
author | Bartell, Heddy Wolchok, Jedd Hodi, F Stephen Liu, Helen Wojtaszek, Cynthia Weber, Jeffrey |
author_facet | Bartell, Heddy Wolchok, Jedd Hodi, F Stephen Liu, Helen Wojtaszek, Cynthia Weber, Jeffrey |
author_sort | Bartell, Heddy |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-4652556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-46525562015-11-25 Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) Bartell, Heddy Wolchok, Jedd Hodi, F Stephen Liu, Helen Wojtaszek, Cynthia Weber, Jeffrey J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4652556/ http://dx.doi.org/10.1186/2051-1426-3-S2-P384 Text en Copyright © 2015 Bartell et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Poster Presentation Bartell, Heddy Wolchok, Jedd Hodi, F Stephen Liu, Helen Wojtaszek, Cynthia Weber, Jeffrey Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) |
title | Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) |
title_full | Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) |
title_fullStr | Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) |
title_full_unstemmed | Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) |
title_short | Immuno-oncology safety education experience: Key lessons from ipilimumab (IPI) |
title_sort | immuno-oncology safety education experience: key lessons from ipilimumab (ipi) |
topic | Poster Presentation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4652556/ http://dx.doi.org/10.1186/2051-1426-3-S2-P384 |
work_keys_str_mv | AT bartellheddy immunooncologysafetyeducationexperiencekeylessonsfromipilimumabipi AT wolchokjedd immunooncologysafetyeducationexperiencekeylessonsfromipilimumabipi AT hodifstephen immunooncologysafetyeducationexperiencekeylessonsfromipilimumabipi AT liuhelen immunooncologysafetyeducationexperiencekeylessonsfromipilimumabipi AT wojtaszekcynthia immunooncologysafetyeducationexperiencekeylessonsfromipilimumabipi AT weberjeffrey immunooncologysafetyeducationexperiencekeylessonsfromipilimumabipi |